MARKET

ADMP

ADMP

Adamis Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8202
-0.2498
-23.35%
Pre Market: 0.8018 -0.0184 -2.24% 08:44 05/06 EDT
OPEN
0.9200
PREV CLOSE
1.070
HIGH
0.9598
LOW
0.8112
VOLUME
59.09K
TURNOVER
--
52 WEEK HIGH
2.340
52 WEEK LOW
0.3755
MARKET CAP
122.12M
P/E (TTM)
-1.3176
1D
5D
1M
3M
1Y
5Y
70 Biggest Movers From Yesterday
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.
Benzinga · 3h ago
ADMP, BGFV, ATNX and ESPR among midday movers
Gainers: Regional Health Properties (RHE) +124%.SunLink Health Systems (SSY) +66%.Nemaura Medical (NMRD) +60%.Chiasma (CHMA) +48%.Athenex (ATNX) +31%.Caesarstone (CSTE) +30%.Hayward (HAYW) +28%.Altisource Portfolio Solutions (ASPS) +26%.Big 5 Sporting Good...
Seekingalpha · 20h ago
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors.
Benzinga · 20h ago
Regional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers
Gainers: Regional Health Properties (RHE) +71%, Chiasma CHMA +45%, Nemaura Medical (NMRD) +35%, Athenex (ATNX) +40%, iBio (IBIO) +29%.Losers: Cocrystal Pharma COCP -32%, Esperion Therapeutics ESPR -26%, Adamis Pharmaceuticals (ADMP) -19%, Precipio (PRPO) -...
Seekingalpha · 21h ago
Alcon, Mercury Systems among premarket losers' pack
Esperion Therapeutics (ESPR) -32% on Q1 earnings release.Cocrystal Pharma (COCP) -27% after launches $40M stock offering.SemiLEDs (LEDS) -21%.Mercury Systems (MRCY) -18% on FQ3 earnings release.Adamis Pharmaceuticals (ADMP) -14%.Reed's (REED) -14% after an...
Seekingalpha · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Benzinga · 1d ago
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics.
Benzinga · 1d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Benzinga · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ADMP. Analyze the recent business situations of Adamis Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ADMP stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 78
Institutional Holdings: 8.41M
% Owned: 5.65%
Shares Outstanding: 148.89M
TypeInstitutionsShares
Increased
12
717.12K
New
3
31.53K
Decreased
6
415.26K
Sold Out
10
1.16M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.68%
Pharmaceuticals & Medical Research
+0.20%
Key Executives
Chairman/Independent Director
Richard Williams
Chief Executive Officer/President/Director
Dennis Carlo
Chief Financial Officer/Senior Vice President - Finance
Robert Hopkins
Senior Vice President/Director
David Marguglio
Vice President - Operations
Karen Daniels
Other
Ronald Moss
Independent Director
Howard Birndorf
Independent Director
Roshawn Blunt
No Data
  • All
  • Financials
  • Insiders
More
About ADMP
Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Webull offers kinds of Adamis Pharmaceuticals Corp stock information, including NASDAQ:ADMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADMP stock methods without spending real money on the virtual paper trading platform.